These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 32248716)
1. Improvements in the multidisciplinary care are beneficial for survival in amyotrophic lateral sclerosis (ALS): experience from a tertiary ALS center. Klavžar P; Koritnik B; Leonardis L; Dolenc Grošelj L; Kirbiš M; Ristić Kovačič S; Klinar P; Pohar Perme M; Zidar J Amyotroph Lateral Scler Frontotemporal Degener; 2020 May; 21(3-4):203-208. PubMed ID: 32248716 [No Abstract] [Full Text] [Related]
2. The impact of clinical factors, riluzole and therapeutic interventions on ALS survival: a population based study in Modena, Italy. Georgoulopoulou E; Fini N; Vinceti M; Monelli M; Vacondio P; Bianconi G; Sola P; Nichelli P; Mandrioli J Amyotroph Lateral Scler Frontotemporal Degener; 2013 Sep; 14(5-6):338-45. PubMed ID: 23373475 [TBL] [Abstract][Full Text] [Related]
3. Riluzole and other prognostic factors in ALS: a population-based registry study in Italy. Mandrioli J; Malerba SA; Beghi E; Fini N; Fasano A; Zucchi E; De Pasqua S; Guidi C; Terlizzi E; Sette E; Ravasio A; Casmiro M; Salvi F; Liguori R; Zinno L; Handouk Y; Rizzi R; Borghi A; Rinaldi R; Medici D; Santangelo M; Granieri E; Mussuto V; Aiello M; Ferro S; Vinceti M; J Neurol; 2018 Apr; 265(4):817-827. PubMed ID: 29404735 [TBL] [Abstract][Full Text] [Related]
4. Percutaneous gastrostomy, mechanical ventilation and survival in amyotrophic lateral sclerosis: an observational study in an incident cohort. Borghero G; Pierri V; Pili F; Muroni A; Ercoli T; Pateri MI; Pilotto S; Maccabeo A; Chiò A; Defazio G Amyotroph Lateral Scler Frontotemporal Degener; 2024 Aug; 25(5-6):563-569. PubMed ID: 38747354 [TBL] [Abstract][Full Text] [Related]
5. Identifying who will benefit from non-invasive ventilation in amyotrophic lateral sclerosis/motor neurone disease in a clinical cohort. Berlowitz DJ; Howard ME; Fiore JF; Vander Hoorn S; O'Donoghue FJ; Westlake J; Smith A; Beer F; Mathers S; Talman P J Neurol Neurosurg Psychiatry; 2016 Mar; 87(3):280-6. PubMed ID: 25857659 [TBL] [Abstract][Full Text] [Related]
7. Survival in amyotrophic lateral sclerosis with home mechanical ventilation: the impact of systematic respiratory assessment and bulbar involvement. Farrero E; Prats E; Povedano M; Martinez-Matos JA; Manresa F; Escarrabill J Chest; 2005 Jun; 127(6):2132-8. PubMed ID: 15947331 [TBL] [Abstract][Full Text] [Related]
8. Is survival improved by the use of NIV and PEG in amyotrophic lateral sclerosis (ALS)? A post-mortem study of 80 ALS patients. Burkhardt C; Neuwirth C; Sommacal A; Andersen PM; Weber M PLoS One; 2017; 12(5):e0177555. PubMed ID: 28542233 [TBL] [Abstract][Full Text] [Related]
9. Slower disease progression and prolonged survival in contemporary patients with amyotrophic lateral sclerosis: is the natural history of amyotrophic lateral sclerosis changing? Czaplinski A; Yen AA; Simpson EP; Appel SH Arch Neurol; 2006 Aug; 63(8):1139-43. PubMed ID: 16908741 [TBL] [Abstract][Full Text] [Related]
10. Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study. Fang T; Al Khleifat A; Meurgey JH; Jones A; Leigh PN; Bensimon G; Al-Chalabi A Lancet Neurol; 2018 May; 17(5):416-422. PubMed ID: 29525492 [TBL] [Abstract][Full Text] [Related]
11. Riluzole and prognostic factors in amyotrophic lateral sclerosis long-term and short-term survival: a population-based study of 1149 cases in Taiwan. Lee CT; Chiu YW; Wang KC; Hwang CS; Lin KH; Lee IT; Tsai CP J Epidemiol; 2013; 23(1):35-40. PubMed ID: 23117224 [TBL] [Abstract][Full Text] [Related]
12. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000. Traynor BJ; Alexander M; Corr B; Frost E; Hardiman O J Neurol Neurosurg Psychiatry; 2003 Sep; 74(9):1258-61. PubMed ID: 12933930 [TBL] [Abstract][Full Text] [Related]